Codiak BioSciences, Inc. reports results for the quarter ended in June - Earnings Summary

Codiak BioSciences,.

05/08/2021 22:21

* Codiak BioSciences, Inc.  CDAK.OQ  reported a quarterly
adjusted loss of 99 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of $1.05 per share.
* Revenue was $890.00 thousand​;  analysts expected $1.35
million. 
* Codiak BioSciences, Inc.'s reported EPS for the quarter was a
loss of 99 cents​.
* The mean earnings estimate of analysts had risen by about 0.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Codiak BioSciences, Inc. shares had fallen by 2.9% this
quarter and lost 44.3% so far this year.
* The company reported a quarterly loss of $21.81 million.
* Wall Street's median 12-month price target for Codiak
BioSciences, Inc. is $34.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 09:21 p.m.  ​All
figures in US dollars unless otherwise stated